Report Detail
Global Cardiovascular Agents Market Insights, Forecast to 2025
- RnM2396463 |
- 05 March, 2019 |
- Global |
- 129 Pages |
- QYResearch |
- Pharma & Healthcare
The global Cardiovascular Agents market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cardiovascular Agents market based on company, product type, end user and key regions.
This report studies the global market size of Cardiovascular Agents in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cardiovascular Agents in these regions.
This research report categorizes the global Cardiovascular Agents market by top players/brands, region, type and end user. This report also studies the global Cardiovascular Agents market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZeneca plc.
Pfizer Inc.
Novartis AG
Merck & Co., Inc.
Bristol-Myers Squibb Company
Bayer AG
Sanofi
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Gilead Sciences, Inc.
Johnson & Johnson
Astellas Pharma, Inc.
Eli Lilly and Company
Otsuka Holdings Co., Ltd.
Takeda Pharmaceutical Company Limited.
Market size by Product
Antianginal Agents
Antiarrhythmic Agents
Inotropic Agents
Miscellaneous Cardiovascular Agents
Peripheral Vasodilators
Renin Inhibitors
Sclerosing Agents
Vasodilators
Market size by End User
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cardiovascular Agents market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cardiovascular Agents market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cardiovascular Agents companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cardiovascular Agents submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cardiovascular Agents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cardiovascular Agents market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Cardiovascular Agents Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Cardiovascular Agents Market Size Growth Rate by Product
- 1.4.2 Antianginal Agents
- 1.4.3 Antiarrhythmic Agents
- 1.4.4 Inotropic Agents
- 1.4.5 Miscellaneous Cardiovascular Agents
- 1.4.6 Peripheral Vasodilators
- 1.4.7 Renin Inhibitors
- 1.4.8 Sclerosing Agents
- 1.4.9 Vasodilators
- 1.5 Market by End User
- 1.5.1 Global Cardiovascular Agents Market Size Growth Rate by End User
- 1.5.2 Retail Pharmacies
- 1.5.3 Hospital Pharmacies
- 1.5.4 Online Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Cardiovascular Agents Market Size
- 2.1.1 Global Cardiovascular Agents Revenue 2014-2025
- 2.1.2 Global Cardiovascular Agents Sales 2014-2025
- 2.2 Cardiovascular Agents Growth Rate by Regions
- 2.2.1 Global Cardiovascular Agents Sales by Regions
- 2.2.2 Global Cardiovascular Agents Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Cardiovascular Agents Sales by Manufacturers
- 3.1.1 Cardiovascular Agents Sales by Manufacturers
- 3.1.2 Cardiovascular Agents Sales Market Share by Manufacturers
- 3.1.3 Global Cardiovascular Agents Market Concentration Ratio (CR5 and HHI)
- 3.2 Cardiovascular Agents Revenue by Manufacturers
- 3.2.1 Cardiovascular Agents Revenue by Manufacturers (2014-2019)
- 3.2.2 Cardiovascular Agents Revenue Share by Manufacturers (2014-2019)
- 3.3 Cardiovascular Agents Price by Manufacturers
- 3.4 Cardiovascular Agents Manufacturing Base Distribution, Product Types
- 3.4.1 Cardiovascular Agents Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Cardiovascular Agents Product Type
- 3.4.3 Date of International Manufacturers Enter into Cardiovascular Agents Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Cardiovascular Agents Sales by Product
- 4.2 Global Cardiovascular Agents Revenue by Product
- 4.3 Cardiovascular Agents Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Cardiovascular Agents Breakdown Data by End User
6 North America
- 6.1 North America Cardiovascular Agents by Countries
- 6.1.1 North America Cardiovascular Agents Sales by Countries
- 6.1.2 North America Cardiovascular Agents Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Cardiovascular Agents by Product
- 6.3 North America Cardiovascular Agents by End User
7 Europe
- 7.1 Europe Cardiovascular Agents by Countries
- 7.1.1 Europe Cardiovascular Agents Sales by Countries
- 7.1.2 Europe Cardiovascular Agents Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Cardiovascular Agents by Product
- 7.3 Europe Cardiovascular Agents by End User
8 Asia Pacific
- 8.1 Asia Pacific Cardiovascular Agents by Countries
- 8.1.1 Asia Pacific Cardiovascular Agents Sales by Countries
- 8.1.2 Asia Pacific Cardiovascular Agents Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Cardiovascular Agents by Product
- 8.3 Asia Pacific Cardiovascular Agents by End User
9 Central & South America
- 9.1 Central & South America Cardiovascular Agents by Countries
- 9.1.1 Central & South America Cardiovascular Agents Sales by Countries
- 9.1.2 Central & South America Cardiovascular Agents Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Cardiovascular Agents by Product
- 9.3 Central & South America Cardiovascular Agents by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Cardiovascular Agents by Countries
- 10.1.1 Middle East and Africa Cardiovascular Agents Sales by Countries
- 10.1.2 Middle East and Africa Cardiovascular Agents Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Cardiovascular Agents by Product
- 10.3 Middle East and Africa Cardiovascular Agents by End User
11 Company Profiles
- 11.1 AstraZeneca plc.
- 11.1.1 AstraZeneca plc. Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AstraZeneca plc. Cardiovascular Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AstraZeneca plc. Cardiovascular Agents Products Offered
- 11.1.5 AstraZeneca plc. Recent Development
- 11.2 Pfizer Inc.
- 11.2.1 Pfizer Inc. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Pfizer Inc. Cardiovascular Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Pfizer Inc. Cardiovascular Agents Products Offered
- 11.2.5 Pfizer Inc. Recent Development
- 11.3 Novartis AG
- 11.3.1 Novartis AG Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Novartis AG Cardiovascular Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Novartis AG Cardiovascular Agents Products Offered
- 11.3.5 Novartis AG Recent Development
- 11.4 Merck & Co., Inc.
- 11.4.1 Merck & Co., Inc. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Merck & Co., Inc. Cardiovascular Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Merck & Co., Inc. Cardiovascular Agents Products Offered
- 11.4.5 Merck & Co., Inc. Recent Development
- 11.5 Bristol-Myers Squibb Company
- 11.5.1 Bristol-Myers Squibb Company Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Bristol-Myers Squibb Company Cardiovascular Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Bristol-Myers Squibb Company Cardiovascular Agents Products Offered
- 11.5.5 Bristol-Myers Squibb Company Recent Development
- 11.6 Bayer AG
- 11.6.1 Bayer AG Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Bayer AG Cardiovascular Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Bayer AG Cardiovascular Agents Products Offered
- 11.6.5 Bayer AG Recent Development
- 11.7 Sanofi
- 11.7.1 Sanofi Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Sanofi Cardiovascular Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Sanofi Cardiovascular Agents Products Offered
- 11.7.5 Sanofi Recent Development
- 11.8 Boehringer Ingelheim GmbH
- 11.8.1 Boehringer Ingelheim GmbH Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Boehringer Ingelheim GmbH Cardiovascular Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Boehringer Ingelheim GmbH Cardiovascular Agents Products Offered
- 11.8.5 Boehringer Ingelheim GmbH Recent Development
- 11.9 F. Hoffmann-La Roche Ltd
- 11.9.1 F. Hoffmann-La Roche Ltd Company Details
- 11.9.2 Company Business Overview
- 11.9.3 F. Hoffmann-La Roche Ltd Cardiovascular Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 F. Hoffmann-La Roche Ltd Cardiovascular Agents Products Offered
- 11.9.5 F. Hoffmann-La Roche Ltd Recent Development
- 11.10 Abbott Laboratories
- 11.10.1 Abbott Laboratories Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Abbott Laboratories Cardiovascular Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Abbott Laboratories Cardiovascular Agents Products Offered
- 11.10.5 Abbott Laboratories Recent Development
- 11.11 Gilead Sciences, Inc.
- 11.12 Johnson & Johnson
- 11.13 Astellas Pharma, Inc.
- 11.14 Eli Lilly and Company
- 11.15 Otsuka Holdings Co., Ltd.
- 11.16 Takeda Pharmaceutical Company Limited.
12 Future Forecast
- 12.1 Cardiovascular Agents Market Forecast by Regions
- 12.1.1 Global Cardiovascular Agents Sales Forecast by Regions 2019-2025
- 12.1.2 Global Cardiovascular Agents Revenue Forecast by Regions 2019-2025
- 12.2 Cardiovascular Agents Market Forecast by Product
- 12.2.1 Global Cardiovascular Agents Sales Forecast by Product 2019-2025
- 12.2.2 Global Cardiovascular Agents Revenue Forecast by Product 2019-2025
- 12.3 Cardiovascular Agents Market Forecast by End User
- 12.4 North America Cardiovascular Agents Forecast
- 12.5 Europe Cardiovascular Agents Forecast
- 12.6 Asia Pacific Cardiovascular Agents Forecast
- 12.7 Central & South America Cardiovascular Agents Forecast
- 12.8 Middle East and Africa Cardiovascular Agents Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Cardiovascular Agents Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Cardiovascular Agents . Industry analysis & Market Report on Cardiovascular Agents is a syndicated market report, published as Global Cardiovascular Agents Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Cardiovascular Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
